Glycosaminoglycan turn-over in articular cartilage.
Glycosaminoglycan turn-over has been studied both in vivo and in vitro, by using sodium [35S]sulphate as a precursor. The in vivo experiments were performed on rabbits and dogs, taking special care to monitor the 35S radioactivity in the serum throughout the experiment and to measure the radioactivity due to unincorporated inorganic [35S]sulphate in cartilage at the end of each experiment, in addition to that due to incorporated sulphate. The inorganic sulphate content of the serum was also determined as well as the distribution coefficient for the inorganic sulphate ion between cartilage and serum. From this information it was possible to calculate accurately the rate of sulphate uptake by cartilage in vivo and hence the turn-over rate. Experiments were then performed in vitro on cartilage from rabbits and dogs and the in vivo and in vitro results were compared. A very good agreement was obtained between the two sets of results. Studies were then carried out under exactly the same in vitro conditions on human articular cartilage and it was thus possible to obtain a turn-over rate for the latter which one could trust was close to the actual in vivo value. The mean half-lives thus obtained varied from 45 days for the young rabbit to 150 days for the adult dog and 800 days for the human femoral head. In human cartilage there were considerable variations in turn-over rate within a single joint as a function of depth below the surface, and between different joints. Thus, while the mean half-life for the human femoral head is 800 days, that for the femoral condyle is 300 days. Cartilage from osteoarthrosic femoral heads did not appear to differ much with respect to sulphate uptake from the normal specimens although the turn-over rates were somewhat higher.
D000328:Adult; D000818:Animals; D002358:Cartilage, Articular / Q000032:analysis / Q000033:anatomy & histology / Q000378:metabolism*; D002807:Chondroitin / Q000378:metabolism; D004285:Dogs; D005270:Femur Head; D006025:Glycosaminoglycans / Q000378:metabolism*; D006615:Hip; D006801:Humans; D007632:Keratan Sulfate / Q000378:metabolism; D007700:Kinetics; D007717:Knee; D008954:Models, Biological; D010003:Osteoarthritis / Q000378:metabolism; D011817:Rabbits; D013431:Sulfates / Q000032:analysis / Q000097:blood / Q000378:metabolism; D013582:Synovial Fluid / Q000378:metabolism
D006025:Glycosaminoglycans; D013431:Sulfates; D002807:Chondroitin; D007632:Keratan Sulfate